Table 3. Submaximal and maximal aerobic capacity data.
Baseline | Following Regular Care |
Following Exercise |
|||||
---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | P value | |
Aerobic Capacity (3 min Stage) | |||||||
N | 13 | 13 | 13 | ||||
Rating Perceived Exertion | 8 | 2 | 8 | 2 | 7bc | 1 | 0.252 |
Submaximal HR (bpm) | 104 | 10 | 103 | 14 | 99b | 13 | 0.281 |
Minute Ventilation (L·min-1) | 23.59 | 8.67 | 17.44°a | 5.97 | 20.83Δc | 4.71 | 0.004* |
Respiratory Exchange Ratio | 0.79 | 0.27 | 0.61°a | 0.07 | 0.72Δc | 0.04 | 0.042* |
VO2 (L·min-1) | 1.13 | 0.30 | 0.83°a | 0.40 | 0.86†b | 0.29 | 0.004* |
VO2 (ml·kg-1·min-1) | 15.84 | 1.70 | 12.05°a | 3.08 | 13.51Δb | 2.55 | 0.010* |
Aerobic Capacity (6 min Stage) | |||||||
N | 13 | 13 | 13 | ||||
Rating Perceived Exertion | 9 | 2 | 9 | 2 | 8†bc | 2 | 0.025* |
Submaximal HR (bpm) | 137 | 17 | 132 | 20 | 122†Δbc | 15 | 0.001* |
Minute Ventilation (L·min-1) | 28.45 | 8.47 | 23.89°a | 8.09 | 23.53†b | 6.23 | 0.007* |
Respiratory Exchange Ratio | 0.86 | 0.29 | 0.67°a | 0.09 | 0.78Δc | 0.04 | 0.048* |
VO2 (L·min-1) | 1.35 | 0.34 | 1.15° | 0.45 | 0.98†Δb | 0.31 | 0.000* |
VO2 (ml·kg-1·min-1) | 18.79 | 2.27 | 16.66°a | 2.48 | 15.26†bc | 2.07 | 0.001* |
Aerobic Capacity (9 min Stage) | |||||||
N | 13 | 13 | 13 | ||||
Rating Perceived Exertion | 11 | 2 | 10a | 2 | 9bc | 2 | 0.142 |
Submaximal HR (bpm) | 161 | 12 | 156 | 14 | 152†b | 12 | 0.002* |
Minute Ventilation (L·min-1) | 35.64 | 12.03 | 28.41°a | 9.15 | 27.57†b | 7.56 | 0.000* |
Respiratory Exchange Ratio | 0.95 | 0.43 | 0.72a | 0.08 | 0.80c | 0.03 | 0.098 |
VO2 (L·min-1) | 1.63 | 0.52 | 1.27°a | 0.58 | 1.14†b | 0.42 | 0.001* |
VO2 (ml·kg-1·min-1) | 22.69 | 4.10 | 19.52°a | 2.63 | 17.30†Δbc | 2.42 | 0.000* |
Aerobic Capacity (Peak) | |||||||
N | 13 | 13 | 13 | ||||
Rating Perceived Exertion | 17 | 2 | 16 | 2 | 17 | 3 | 0.319 |
Maximal Heart Rate (bpm) | 184 | 10 | 180 | 16 | 181 | 15 | 0.201 |
Minute Ventilation (L·min-1) | 73.18 | 30.86 | 62.44 | 23.16 | 68.85 | 22.29 | 0.114 |
Respiratory Exchange Ratio | 0.98 | 0.08 | 0.91°a | 0.09 | 1.01Δc | 0.08 | 0.003* |
VO2peak (L·min-1) | 2.72 | 1.03 | 2.46 | 1.10 | 2.51 | 1.14 | 0.163 |
VO2peak (ml·kg-1·min-1) | 38.50 | 12.32 | 37.35 | 11.94 | 38.53 | 12.92 | 0.431 |
VO2peak (ml·LBM-1·min-1) | 61.07 | 10.04 | 60.74 | 10.91 | 58.25 | 11.25 | 0.261 |
HR, heart rate; LBM, lean body mass.
*Denotes statistical significance (p ≤ 0.05) between time points using One-Way Repeated Measures ANOVA
°Denotes statistical significance (p ≤ 0.05) between Baseline and Regular Care using post-hoc paired t-tests
†Denotes statistical significance (p ≤ 0.05) between Baseline and Exercise using post-hoc paired t-tests
ΔDenotes statistical significance (p ≤ 0.05) between Regular Care and Exercise using post-hoc paired t-tests
aDenotes moderate to large effect size (d = ≥ 0.5) between Baseline and Regular Care using Cohen’s D effect sizes
bDenotes moderate to large effect size (d = ≥ 0.5) between Baseline and Exercise using Cohen’s D effect sizes
cDenotes moderate to large effect size (d = ≥ 0.5) between Regular Care and Exercise using Cohen’s D effect sizes